Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIM-PTL: Optimization of treatment of pregnant women with preterm labor using prediction models
2020-005202-26Phase 3Active
- Sponsor
- IDIBAPS
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of betamethasone sodium phosphate + betamethasone acetate in Preterm labor (PTL) and preterm birth (2 arms), sponsored by IDIBAPS. Primary endpoint: Number of antenatal steroid doses administered. Started Jan 2026; status: active.
02
Drugs
betamethasone sodium phosphate + betamethasone acetate
03
Conditions
Preterm labor (PTL)preterm birth
Beyond the preview
Go deeper on 2020-005202-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005202-26.